Free Trial

Patient Square Capital Lp Top Holdings and 13F Report (2024)

About Patient Square Capital Lp

Investment Activity

  • Patient Square Capital Lp has $269.41 million in total holdings as of September 30, 2024.
  • Patient Square Capital Lp owns shares of 11 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
  • Approximately 20.96% of the portfolio was purchased this quarter.
  • This quarter, Patient Square Capital Lp has purchased 2 new stocks and bought additional shares in 0 stocks.
  • Patient Square Capital Lp sold shares of 0 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

Roivant Sciences
$141,116,486
Liquidia
$71,825,320
Insmed
$12,534,392

Largest New Holdings this Quarter

Cullinan Therapeutics
$13,805,562 Holding
Insmed
$12,534,392 Holding
EyePoint Pharmaceuticals
$10,882,212 Holding
Nurix Therapeutics
$7,320,479 Holding
Pharvaris
$4,488,155 Holding

Largest Purchases this Quarter

Cullinan Therapeutics
824,705 shares (about $13.81M)
Insmed
171,704 shares (about $12.53M)
EyePoint Pharmaceuticals
1,361,979 shares (about $10.88M)
Nurix Therapeutics
325,789 shares (about $7.32M)
Pharvaris
242,341 shares (about $4.49M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofPatient Square Capital Lp

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$141,116,4860.0%12,228,46552.4%Medical
Liquidia Co. stock logo
LQDA
Liquidia
$71,825,3200.0%7,182,53226.7%Medical
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
$13,805,562$13,805,562 New Holding824,7055.1%Medical
Insmed Incorporated stock logo
INSM
Insmed
$12,534,392$12,534,392 New Holding171,7044.7%Medical
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$10,882,212$10,882,212 New Holding1,361,9794.0%Medical
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
$7,320,479$7,320,479 New Holding325,7892.7%Medical
Pharvaris stock logo
PHVS
Pharvaris
$4,488,155$4,488,155 New Holding242,3411.7%Medical
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$2,642,093$2,642,093 New Holding128,5691.0%Medical
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$2,313,209$2,313,209 New Holding90,5720.9%Medical
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$2,048,833$2,048,833 New Holding235,4980.8%Medical
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
$434,036$434,036 New Holding39,4220.2%Medical

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data